HLA-DQA1*05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn’s disease A Sazonovs, NA Kennedy, L Moutsianas, GA Heap, DL Rice, M Reppell, ... Gastroenterology 158 (1), 189-199, 2020 | 332 | 2020 |
NetworKit: A tool suite for large-scale complex network analysis CL Staudt, A Sazonovs, H Meyerhenke Network Science 4 (4), 508–530, 2016 | 315* | 2016 |
Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility A Sazonovs, CR Stevens, GR Venkataraman, K Yuan, B Avila, MT Abreu, ... Nature genetics 54 (9), 1275-1283, 2022 | 87* | 2022 |
Common and rare variant prediction and penetrance of IBD in a large, multi-ethnic, health system-based biobank cohort K Gettler, R Levantovsky, A Moscati, M Giri, Y Wu, NY Hsu, LS Chuang, ... Gastroenterology 160 (5), 1546-1557, 2021 | 52* | 2021 |
Rare-variant studies to complement genome-wide association studies A Sazonovs, JC Barrett Annual Review of Genomics and Human Genetics 19, 97-112, 2018 | 36 | 2018 |
Underpowered PANTS: a response to the conclusions of “extended analysis identifies drug-specific association of two distinct HLA class II haplotypes for development of … A Sazonovs, T Ahmad, CA Anderson Gastroenterology 160 (1), 470-471, 2021 | 13 | 2021 |
Delay tolerant networking for the socio-economic development in rural South Africa A Galati, A Sazonovs, M Olivares, S Mangold, TR Gross Smart Objects and Technologies for Social Good: Second International …, 2017 | 5 | 2017 |
Exploring the potential clinical utility of NUDT15 pharmacogenetic testing in clinical practice: a'focused reverse phenotyping'study in the UK IBD Bioresource C Roberts, A Sazonovs, R Smith, M Bishara, S Lin, C Neil, C Bewshea, ... JOURNAL OF CROHNS & COLITIS 18, I19-I20, 2024 | | 2024 |
OP11 Exploring the potential clinical utility of NUDT15 pharmacogenetic testing in clinical practice: a ‘focused reverse phenotyping’study in the UK IBD Bioresource C Roberts, A Sazonovs, R Smith, M Bishara, S Lin, C Neil, C Bewshea, ... Journal of Crohn's and Colitis 18 (Supplement_1), i19-i20, 2024 | | 2024 |
Prevalence of NUDT15 genetic variants and incidence of thiopurine-induced myelosuppression in inflammatory bowel disease: A systematic review and meta-analysis N Yu, D Sriranganathan, G Walker, A Sazonovs, H Wilding, C Roberts, ... Journal of Gastroenterology and Hepatology 38, 114-114, 2023 | | 2023 |
P440 Prevalence of NUDT15 polymorphisms and incidence of thiopurine-induced leukopenia in Inflammatory Bowel Disease patients: A systematic review and meta-analysis N Yu, D Sriranganathan, GJ Walker, A Sazonovs, H Wilding, NA Kennedy, ... Journal of Crohn's and Colitis 17 (Supplement_1), i569-i570, 2023 | | 2023 |
Prevalence of NUDT15 polymorphisms and incidence of thiopurine-induced leukopenia in Inflammatory Bowel Disease patients: A systematic review and meta-analysis N Yu, D Sriranganathan, GJ Walker, A Sazonovs, H Wilding, NA Kennedy, ... | | 2023 |
Alteration of the gut microbiota’s composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters A Sazonovs, C Stevens, G Venkataraman, K Yuan, B Avila, M Abreu, ... Gut microbes 14 (1), 1275-1283, 2022 | | 2022 |
The Genetics of IBD: From Susceptibility to Drug Response and Patient Outcome A Sazonovs | | 2020 |
HLA-DQA1* 05 begünstigt Medikamenten-Antikörper gegen Infliximab und Adalimumab A Sazonovs Z Gastroenterol, 58, 2020 | | 2020 |
NETWORKIT: AN INTERACTIVE TOOL FOR HIGH-PERFORMANCE NETWORK ANALYSIS CL Staudt, A Sazonovs, H Meyerhenke CSC14: The Sixth SIAM Workshop on Combinatorial Scientific Computing, 41, 2014 | | 2014 |